Umb Bank, N.A. Amphastar Pharmaceuticals, Inc. Transaction History
Umb Bank, N.A.
- $6.26 Billion
- Q2 2025
A detailed history of Umb Bank, N.A. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 19 shares of AMPH stock, worth $450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19
Previous 227
91.63%
Holding current value
$450
Previous $5,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AMPH
# of Institutions
260Shares Held
33.1MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$141 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$63.8 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$48.3 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$38.6 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$37.4 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.16B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...